November 23, 2014 11:08 PM ET

Pharmaceuticals

Company Overview of Colby Pharmaceutical Company

Company Overview

Colby Pharmaceutical Company, a clinical stage drug development company, focuses on non-toxic signal transduction and hypoxia inhibitor drug therapeutics specifically targeting survival pathways in solid tumor cells, immune or immune suppressed cells, and vas-occlusive conditions. The company primarily focuses on therapeutic areas, such as prostate and brain cancer. Its products include CPC-100, an anti-androgenic, anti-inflammatory, multi-targeted signal transduction inhibitor drug for the treatment of androgen-dependent prostate tumors; CPC-200, a synthetic drug that irreversibly binds to and inactivates the oxidase enzyme producing hydrogen peroxide in the cell cytoplasm of various types ...

5941 Optical Court

Suite 223

San Jose, CA 95138

United States

Founded in 2004

Phone:

650-333-3152

Key Executives for Colby Pharmaceutical Company

Chief Executive Officer and Director
Chief Medical Officer
Age: 56
Vice President and Director
Chief Scientific Officer
Compensation as of Fiscal Year 2014.

Colby Pharmaceutical Company Key Developments

Colby Pharmaceutical Company Presents at Boston Biotech Conferences LLC's East/West CEO Conference, Jan-12-2014 01:00 PM

Colby Pharmaceutical Company Presents at Boston Biotech Conferences LLC's East/West CEO Conference, Jan-12-2014 01:00 PM. Venue: Four Seasons Hotel, San Francisco, California, United States. Speakers: David A. Zarling, Chief Executive Officer and Director.

Colby Pharmaceutical Company Presents at Sachs Associates Ltd.'s 6th Annual European Life Sciences CEO Forum, Mar-05-2013 11:00 AM

Colby Pharmaceutical Company Presents at Sachs Associates Ltd.'s 6th Annual European Life Sciences CEO Forum, Mar-05-2013 11:00 AM. Venue: Hilton Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152 Zurich, Switzerland. Speakers: Thomas Kunding, Director.

Colby Pharmaceutical Company Presents at Boston Biotech Conferences LLC's East/West CEO Conference, Jan-06-2013 01:00 PM

Colby Pharmaceutical Company Presents at Boston Biotech Conferences LLC's East/West CEO Conference, Jan-06-2013 01:00 PM. Venue: Four Seasons Hotel, San Francisco, California, United States. Speakers: David A. Zarling, Chief Executive Officer and Director.

Similar Private Companies By Industry

Company Name Region
Norian Corporation United States
Koloseum Nutritional Sciences, Inc. United States
Satiogen Pharmaceuticals, Inc. United States
Tego BioSciences Corporation United States
Parion Sciences, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Colby Pharmaceutical Company, please visit www.colbypharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.